At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IFN The India Fund Inc
Pre-Mkt 07-21 05:39:25 EDT
11.39
-0.11
-0.96%
High11.52Low11.39Vol109.89K
Open11.50D1 Closing11.50Amplitude1.17%
Mkt Cap485.81MTradable Cap485.81MTotal Shares42.65M
T/O1.26MT/O Rate0.26%Tradable Shares42.65M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Press Release: Aberdeen Investments U.S. Closed-end Funds Announce Distribution Payment Details
Dow Jones  ·  07-01
Press Release: Aberdeen Investments U.S. Closed-end Funds Announce Distribution Payment Details
Aberdeen India Fund Director of Adviser Steven Maguire Files Initial Beneficial Ownership Statement
Reuters  ·  06-25
Aberdeen India Fund Director of Adviser Steven Maguire Files Initial Beneficial Ownership Statement
India's NIFTY 50 Index Records 1.2% Decline
Deep News  ·  06-23
India's NIFTY 50 Index Records 1.2% Decline
INSTANT VIEW-India's economy grows 7.8% in January-March
Reuters  ·  06-05
INSTANT VIEW-India's economy grows 7.8% in January-March
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
GlobeNewswire  ·  06-04
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
GlobeNewswire  ·  06-01
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
Press Release: ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
Dow Jones  ·  05-28
Press Release: ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE RESULTS OF ANNUAL MEETING OF SHAREHOLDERS
Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026
GlobeNewswire  ·  05-18
Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026
Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
GlobeNewswire  ·  05-13
Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update
Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
Dow Jones  ·  05-12
Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
Press Release: Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting
Dow Jones  ·  04-28
Press Release: Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting
India Is Pitching Wall Street. What to Be Careful Of. -- Barrons.com
Dow Jones  ·  04-10
India Is Pitching Wall Street. What to Be Careful Of. -- Barrons.com
Aberdeen India Fund announces annual shareholder meeting
Reuters  ·  04-08
Aberdeen India Fund announces annual shareholder meeting
Press Release: Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Dow Jones  ·  04-01
Press Release: Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details
Anand Rathi Wealth Secures SEBI Nod for New NIFTY Accelerator AIF Scheme
TIPRANKS  ·  03-16
Anand Rathi Wealth Secures SEBI Nod for New NIFTY Accelerator AIF Scheme
NIFTY Index Advances 0.9% to 23,356.30 in Preliminary Close
Deep News  ·  03-16
NIFTY Index Advances 0.9% to 23,356.30 in Preliminary Close
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
GlobeNewswire  ·  03-10
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Infragreen Group Limited (IFN) Gets a Buy from Morgans
TIPRANKS  ·  02-25
Infragreen Group Limited (IFN) Gets a Buy from Morgans
The India Fund Inc. Renames to Aberdeen India Fund Inc
Reuters  ·  02-13
The India Fund Inc. Renames to Aberdeen India Fund Inc
Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
Dow Jones  ·  02-11
Press Release: Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

Introduction

Company Name.
The India Fund Inc
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
The India Fund, Inc. is a close ended equity mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. The fund invests in public equity markets of India. It seeks to invest in stocks of small-cap, mid-cap, and large-cap companies. The fund employs a quantitative and fundamental analysis with a bottom-up stock picking and asset allocation approach to create its portfolio. It benchmarks the performance of its portfolio against the IFC Investable India Index. The India Fund, Inc. was formed on December 27, 1993 and is domiciled in the Singapore.
Issue price:
--